70.07 USD
↘ 2.87 (3.93%)LIVE (AS OF 11:58 AM EST)
Corcept Therapeutics Inc. (CORT) trades at $70.07 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Furthermore, CORT is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.